HBVAXPRO 10 micrograms, suspension for injection in a pre-filled syringe. hepatitis B vaccine (rDNA) syringe, 1 ml
Active ingredients: ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANT
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 1 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HBVAXPRO 10 microgrammes, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 1 ml avec 2 aiguille(s)
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64646891CIP73692464CIP133400936924642Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANTsuspension | 10 microgrammes · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.